| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.32 | 1e-21 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-12 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.32 | 1e-11 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-09 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-08 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-07 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 4e-05 |